{"knowledge_schema": {"broad_category": "Medicine \u2192 Neurology \u2192 Intracranial Hypertension", "refinement": "This problem pertains to the management and physiological effects of medications used in treating idiopathic intracranial hypertension (IIH).", "specific_scope": "The focus is on the relationship between acetazolamide treatment and its impact on intraocular pressure in patients experiencing sudden remission of IIH.", "goal": "Determine the expected outcome of intraocular pressure tests in patients continuing acetazolamide after a remission of IIH."}, "summary": "This question addresses the effects of acetazolamide on intraocular pressure in patients with idiopathic intracranial hypertension. In cases of sudden remission, if the patient continues taking acetazolamide, the expected observation on an intraocular pressure test would be low intraocular pressure. This is due to acetazolamide's mechanism of action, which reduces cerebrospinal fluid production and consequently lowers both intracranial and intraocular pressure."}